Please check your internet connection and try again.
# Citral
## Overview
Citral is a mixture of two acyclic monoterpene acyclic alcohols, geranial and neral. It is found in the oils of many plants, including lemon myrtle, lemon verbena, and lemon. It is used in the food and fragrance industries. There is limited clinical trial data regarding its use as a pharmaceutical agent.
## Primary Indications
* **Topical use for fungal infections:** Some evidence suggests efficacy for topical treatment of fungal infections, particularly due to *Candida* species. However, it is not a first-line or widely recognized antifungal agent.
## Adult Dosing
* **Topical:** Dosing and preparation vary significantly. Various concentrations have been explored in small studies (e.g., 2.5% to 10% creams). Exact dosing depends on the specific formulation and intended use. Due to lack of standardization and robust clinical data, specific dosing recommendations cannot be definitively provided.
## Pediatric Dosing
* **Topical:** Safety and efficacy have not been established in pediatric populations. Use is not recommended.
## Dose Adjustments
* **Renal Impairment:** No specific recommendations due to limited systemic absorption and use.
* **Hepatic Impairment:** No specific recommendations due to limited systemic absorption and use.
## Contraindications
* Hypersensitivity to citral or any component of the formulation.
* Application to broken or severely inflamed skin is generally not advised due to potential for irritation.
## Adverse Effects
* **Topical:** Skin irritation, redness, itching, burning sensation. Allergic contact dermatitis is possible.
## Key Drug Interactions
* No significant drug interactions have been well-documented in clinical literature, likely due to limited systemic absorption and use.
## Monitoring
* Monitor for signs of local irritation or allergic reaction at the application site.
## Clinical Pearls
* Citral is primarily used as a flavoring and fragrance agent. Its therapeutic application, particularly for fungal infections, is based on limited evidence and is not a standard treatment.
* Formulations and concentrations are not standardized, making direct comparisons and recommendations difficult.
* Its efficacy and safety profile are not as well-established as conventional antifungal agents.
***
*Disclaimer: This information is intended for clinical decision support and does not replace professional medical judgment. Always consult the most current prescribing information and relevant literature for definitive guidance.*
